Research Topics
| M A PerazellaSummaryAffiliation: Yale University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrineHeidi Hoeben
Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520-8029, USA
Am J Kidney Dis 39:102-7. 2002..Cool dialysate and midodrine appear to improve intradialytic hemodynamics in patients with dialysis-associated hypotension, mainly through the preservation of CBV and CO, rather than significantly elevating PVR...
Onco-nephrology: renal toxicities of chemotherapeutic agentsMark A Perazella
Section of Nephrology, Department of Medicine, Yale University, 330 Cedar Street, New Haven, CT 06520 8029, USA
Clin J Am Soc Nephrol 7:1713-21. 2012..Onco-Nephrology is a new area that is rapidly expanding and requires a close working relationship between oncologists and nephrologists...
Drug use and nephrotoxicity in the intensive care unitMark A Perazella
Department of Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520 8029, USA
Kidney Int 81:1172-8. 2012....
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic reviewDinna N Cruz
Department of Nephrology, Ospedale San Bortolo, Viale Rodolfi 37, 36100 Vicenza, Italy
Crit Care 11:R47. 2007..We performed a systematic review to describe the effect in septic patients of direct hemoperfusion with PMX-F on outcomes of blood pressure, use of vasoactive drugs, oxygenation, and mortality reported in published studies...
Increased mortality in chronic kidney disease: a call to actionMark A Perazella
Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Am J Med Sci 331:150-3. 2006..Therefore, therapies targeting both progression of chronic kidney disease and comorbidities such as cardiovascular disease are required to reduce mortality among these patients...
Renal vulnerability to drug toxicityMark A Perazella
Section of Nephrology, Department of Medicine, Yale University, New Haven, Connecticut 06520 8029, USA
Clin J Am Soc Nephrol 4:1275-83. 2009..Recognizing risk factors that increase renal vulnerability to drug-induced kidney disease is the first step in reducing the renal complications of drugs and toxins...
Efficacy and safety of midodrine in the treatment of dialysis-associated hypotensionMark A Perazella
Section of Nephrology, Department of Medicine, Yale University School of Medicine, LMP 2071, 333 Cedar Street, New Haven, CT 06520 8029, USA
Expert Opin Drug Saf 2:37-47. 2003..This medication has been demonstrated to be effective and safe in the acute and chronic treatment of haemodialysis-associated hypotension in end stage renal disease patients...
Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicityMark A Perazella
Department of Medicine, Yale University School of Medicine, New Haven, CT 06520 8029, USA
Am J Med Sci 325:349-62. 2003..Agents recently described to induce an "osmotic nephrosis" include intravenous immunoglobulin and the plasma expander hydroxyethyl starch...
Radiocontrast-induced nephropathy: an updateM A Perazella
Acute Dialysis Services, Section of Nephrology, Department of Medicine, Yale University School of Medicine, FMP 107, 333 Cedar Street, New Haven, CT 06520 8029, USA
Minerva Urol Nefrol 61:215-33. 2009..Several therapies have no role in the prevention of RCIN and should be avoided. This review will provide an up to date examination of the current status of these issues as they relate to RCIN...
Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patientsMark A Perazella
Section of Nephrology, Yale University, New Haven, CT 06520 8029, USA
Clin J Am Soc Nephrol 5:402-8. 2010..Although urine microscopy is useful to differentiate AKI, its role in predicting adverse clinical outcomes has not been well described...
Current status of gadolinium toxicity in patients with kidney diseaseMark A Perazella
Department of Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Clin J Am Soc Nephrol 4:461-9. 2009..This article reviews the current status of GBC agents as nephrotoxins and causes of NSF and provides opinions on how to use these agents in patients with underlying kidney disease...
Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patientsMark A Perazella
Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520 8029, USA
Clin J Am Soc Nephrol 3:1615-9. 2008..Urine microscopy is the oldest and one of the most commonly used tests for differential diagnosis of acute kidney injury (AKI), but its performance has not been adequately studied in the setting of AKI...
Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosisMark A Perazella
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Curr Drug Saf 3:67-75. 2008..Peritoneal dialysis clearance of gadolinium is poor, but aggressive peritoneal dialysis prescriptions have not been studied for gadolinium removal...
Nephrogenic systemic fibrosis and gadolinium-based contrast: what's a nephrologist to do?Mark A Perazella
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Semin Dial 21:121-2. 2008
Nephrogenic systemic fibrosis: recommendations for gadolinium-based contrast use in patients with kidney diseaseMark A Perazella
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Semin Dial 21:171-3. 2008..These clinical practice guidelines should be individualized and considered in consultation with the ordering physician, radiologist, and nephrologist...
Tissue deposition of gadolinium and development of NSF: a convergence of factorsMark A Perazella
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Semin Dial 21:150-4. 2008..Direct gadolinium activation of transglutaminases on these tissue fibroblast-like cells may also promote fibrosis...
PharmacologyMark A Perazella
Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520-8029, USA
Am J Kidney Dis 46:1129-39. 2005
Drug-induced nephropathy: an updateMark A Perazella
Yale University School of Medicine, FMP 107, 300 Cedar Street, New Haven, CT 06520 8029, USA
Expert Opin Drug Saf 4:689-706. 2005..Finally, postrenal azotemia from structural or functional obstruction of the urinary tract also complicates therapy with a number of medications...
Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathyMark A Perazella
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06410, USA
Kidney Int 78:1060-3. 2010..Herlitz et al. confirm the nephrotoxicity of tenofovir in humans. They describe its clinical consequences, histopathologic findings, and its mitochondrial toxicity in HIV+ patients...
Are selective COX-2 inhibitors nephrotoxic?M A Perazella
Department of Internal Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520, USA
Am J Kidney Dis 35:937-40. 2000..We present two cases of acute renal failure complicating the course of therapy with celecoxib in patients with chronic renal insufficiency...
Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and managementM A Perazella
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Drug Saf 22:227-36. 2000....
Acute renal failure in HIV-infected patients: a brief review of common causesM A Perazella
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Am J Med Sci 319:385-91. 2000..Finally, obstruction of the urinary system will rarely cause postrenal azotemia in patients infected with HIV...
Traditional urinary biomarkers in the assessment of hospital-acquired AKIMark A Perazella
Section of Nephrology, Yale University School of Medicine, BB 114, 330 Cedar Street, New Haven, CT 06520 8029, USA
Clin J Am Soc Nephrol 7:167-74. 2012....
Pharmacologic options available to treat symptomatic intradialytic hypotensionM A Perazella
Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520 8029, USA
Am J Kidney Dis 38:S26-36. 2001..A few therapies appear to be efficacious and well tolerated-carnitine, sertraline, and midodrine. This article reviews the various pharmacologic therapies used for IDH and makes recommendations for treatment of this difficult problem...
COX-2 selective inhibitors: analysis of the renal effectsMark A Perazella
Acute Dialysis Services, Section of Nephrology, Department of Medicine, Yale University School of Medicine, LMP 2071, 333 Cedar Street, New Haven, CT 06520 8029, USA
Expert Opin Drug Saf 1:53-64. 2002..Available clinical data on the renal effects of COX-2 selective inhibitors in humans also demonstrate nephrotoxic potential...
Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapyMark A Perazella
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA
Semin Nephrol 30:570-81. 2010..This article reviews some of the classic nephrotoxic chemotherapeutic agents and focuses on examples of the clinical and histopathologic kidney lesions they cause as well as measures that may prevent or treat drug-induced nephrotoxicity...
Imaging patients with kidney disease: how do we approach contrast-related toxicity?Mark A Perazella
Section of Nephrology, Department of Medicine, Yale University School of Medicine, VA Connecticut Health Care System, New Haven, 06520 8029, USA
Am J Med Sci 341:215-21. 2011..This will allow one to maximize the diagnostic efficiency while also limiting the adverse effects...
NSAIDs and the kidney revisited: are selective cyclooxygenase-2 inhibitors safe?J Eras
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Am J Med Sci 321:181-90. 2001..We also touch on the COX-1/COX-2 selectivity of NSAIDs, the localization of COX enzymes in kidneys, and clinical studies examining the renal effects of selective COX-2 inhibitors...
Experience with outpatient computed tomographic-guided renal biopsyA Margaryan
Section of Nephrology, Yale School of Medicine, New Haven, CT, USA
Clin Nephrol 74:440-5. 2010..Transfusion was required in 1 patient while 6 patients had detectable bleeding and were hospitalized for observation. Outpatient CT-guided kidney biopsy provides adequate tissue and appears to be safe with very low complication rates...
COX-2 inhibitors and the kidneyM A Perazella
Yale University School of Medicine, New Haven, Conn, USA
Hosp Pract (Minneap) 36:43-6, 55-6. 2001..COX-2 inhibitors may thus have much the same renal risks that a standard NSAID does. Several clinical trials have already focused on the new drugs' renal effects...
Crystal-induced acute renal failureM A Perazella
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Am J Med 106:459-65. 1999..Management of established renal insufficiency includes volume repletion, dialytic support if necessary, adjustment of drug doses, and avoidance of further exposure to nephrotoxins...
Proton pump inhibitors and the kidney: critical reviewU C Brewster
Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520 8029, USA
Clin Nephrol 68:65-72. 2007..This paper will critically review the effect of PPIs on the kidney...
Treatment of Severe Intradialytic Hypotension With the Addition of High Dialysate Calcium Concentration to Midodrine and/or Cool DialysateR Alappan
Section of Nephrology, Yale University School of Medicine, New Haven, CT, USA
Am J Kidney Dis 37:294-9. 2001..However, this therapy did not reduce symptoms or interventions required for IDH. In addition, hypercalcemia complicated this therapy in 22% of the patients...
Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect stormMark A Perazella
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Curr Opin Nephrol Hypertens 18:519-25. 2009..However, many patients with kidney disease are exposed to GBC agents, yet they do not develop this devastating disorder...
Imaging patients with kidney disease in the era of NSF: can it be done safely?V Manjunath
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520 8029, USA
Clin Nephrol 75:279-85. 2011....
Acute hyperkalemia associated with intravenous epsilon-aminocaproic acid therapyM A Perazella
Department of Medicine, Yale University, New Haven, CT, USA
Am J Kidney Dis 33:782-5. 1999..Hence, it appears that intravenous epsilon-aminocaproic acid can also cause hyperkalemia in humans...
The cardiovascular implications of hypokalemiaSteven G Coca
Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520 8029, USA
Am J Kidney Dis 45:233-47. 2005..We review the available data and draw conclusions about the relative benefits of modulating potassium balance versus nonrenal effects of aldosterone blockade in patients with cardiovascular disease...
Serum vasopressin response in patients with intradialytic hypotension: a pilot studyMira Rho
Yale University School of Medicine, New Haven, CT 06520, USA
Clin J Am Soc Nephrol 3:729-35. 2008..Arginine vasopressin (AVP), an endogenous hormone with vasopressor properties, may be inadequately secreted during episodes of intradialytic hypotension (IDH)...
Drug-induced crystal nephropathy: an updateSri G Yarlagadda
Yale University School of Medicine, Section of Nephrology Department of Medicine, LMP 2071, 333 Cedar Street, New Haven, CT 06520 8029, USA
Expert Opin Drug Saf 7:147-58. 2008....
Transition of patients from chronic kidney disease to end-stage renal disease: better practices for better outcomesChester A Amedia
Department of Internal Medicine, Northeastern Ohio Universities College of Medicine, Boardman, Ohio 44512, USA
Dis Manag 9:311-5. 2006
Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factorsR F Reilly
Department of Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520, USA
Am J Kidney Dis 38:E23. 2001..We review the literature of renal syndromes associated with indinavir focusing on chronic progressive tubulointerstitial injury and speculate on risk factors and potential mechanisms of indinavir-induced renal injury...
Nonhematologic complications of erythropoietin therapyXiaolei Zhu
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA
Semin Dial 19:279-84. 2006..Finally, other less common adverse effects, although rare in most patients, should be recognized as such by physicians who prescribe rHuEPO...
Renal disease in patients with HIV infection: epidemiology, pathogenesis and managementDerek M Fine
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Drugs 68:963-80. 2008..Only with greater awareness of kidney-disease manifestations and their implications in this particularly vulnerable population will we be able to achieve success in confronting this growing problem...
Reliability of a noninvasive device to measure systemic hemodynamics in hemodialysis patientsShaheen Motiwala
Section of Nephrology, Yale University, New Haven, Connecticut, USA
Blood Press Monit 11:33-6. 2006..Other hemodynamic parameters fared similarly, and coefficients of variation were all between 7 and 18%. CONCLUSION: We conclude that the Dynapulse 500 Guardian has adequate reliability indices in hemodialysis patients...
Addition of sertraline to other therapies to reduce dialysis-associated hypotensionUrsula C Brewster
Yale University School of Medicine, Section of Nephrology, New Haven, CT 06520, USA
Nephrology (Carlton) 8:296-301. 2003..In conclusion, it appears that sertraline has no additive effect on intradialytic haemodynamics to improve blood pressure in patients with DAH who are under therapy (with sodium modelling, cool dialysate and midodrine)...
Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicitySteven Coca
Section of Nephrology, Department of Medicine, Yale University School of Medicine, LMP 2071, 333 Cedar Street, New Haven, CT 06520-8029, USA
Am J Med Sci 324:342-4. 2002..We present a case in which acute renal failure developed after therapy with tenofovir DF in a patient with HIV and stable chronic kidney disease...
Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasisM A Perazella
Department of Medicine, Yale University School of Medicine, New Haven, Conn 06520 8029, USA
J Gen Intern Med 12:646-56. 1997....
Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney diseaseMark A Perazella
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Conn, USA
Am J Med 120:561-2. 2007
Nephrogenic systemic fibrosis: what the hospitalist needs to knowDerek M Fine
Department of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
J Hosp Med 5:46-50. 2010..Unfortunately there is a lack of a universally effective therapy. Resolution of acute kidney injury (AKI) appears to attenuate disease in most cases, while kidney transplantation has been associated with variable success...
Recognition, treatment, and prevention of propylene glycol toxicityTausif Zar
Sections of Nephrology, Department of Medicine, University of Connecticut, Farmington, Connecticut 06030, USA
Semin Dial 20:217-9. 2007..Treatment of toxicity includes hemodialysis to effectively remove propylene glycol. Prevention is best achieved by limiting the dose of propylene glycol infused...
Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disordersMark A Perazella
Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn. 06520-8017, USA
J Nucl Cardiol 10:184-96. 2003....
Cachexia in a 53-year-old end-stage renal disease patient on hemodialysisChirag Vaidya
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Semin Dial 20:475-6. 2007
The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease statesUrsula C Brewster
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Am J Med Sci 326:15-24. 2003....
Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and managementMehmet Kanbay
Department of Medicine, Section of Nephrology, Fatih University School of Medicine, Ankara, Turkey
Blood Purif 29:1-12. 2010..The aim of the present review is to provide an update of the recent literature on causes and possible management of ESA-resistant anemia in CKD patients...
Cardiac troponins: utility in renal insufficiency and end-stage renal diseaseSuzanne Watnick
Department of Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA
Semin Dial 15:66-70. 2002....
Nephrotoxicity associated with antiretroviral therapy in HIV-infected patientsMira Rho
Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8029, USA
Curr Drug Saf 2:147-54. 2007..Recognition of drug-related nephrotoxicity will promote earlier resolution of acute kidney injury and reduce the development of chronic kidney disease...
Acute kidney injury following proton pump inhibitor therapyU C Brewster
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06520-9029, USA
Kidney Int 71:589-93. 2007
Acute renal failure after cardiac transplantation: a case report and review of the literatureD N Cruz
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA
Yale J Biol Med 69:461-8. 1996..A case illustrating the typical clinical presentation of ARF after heart transplant will be presented and the clinical features will be reviewed...
Posttransplant erythrocytosis: case report and review of newer treatment modalitiesM A Perazella
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510
J Am Soc Nephrol 3:1653-9. 1993..Theophylline, which reduces adenosine-mediated erythropoietin synthesis, is effective but may be associated with side effects.(ABSTRACT TRUNCATED AT 250 WORDS)..
A review of chronic lead intoxication: an unrecognized cause of chronic kidney diseaseUrsula C Brewster
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA
Am J Med Sci 327:341-7. 2004..In particular, treatment with calcium EDTA chelation may benefit certain patients with chronic kidney disease by slowing the progression to end-stage renal disease...
Intradialytic administration of amphotericin B: clinical observations on efficacy and safetyJames E Wood
Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
Am J Med Sci 327:5-8. 2004..CONCLUSIONS: Intradialytic administration of amphotericin B was generally well tolerated. Our observations suggest that amphotericin B is effective and safe for outpatient intradialytic therapy when administered according to protocol...
Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney diseaseMark A Perazella
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Semin Dial 16:276-80. 2003..In contrast to scleroderma, inflammatory cells are generally absent. Corticosteroid therapy can be tried, but in our patient was of no benefit...
The renin-angiotensin-aldosterone system and the kidney: effects on kidney diseaseUrsula C Brewster
Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA
Am J Med 116:263-72. 2004....
Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial?Steven G Coca
Yale University School of Medicine, New Haven, CT 06520 8029, USA
Expert Rev Cardiovasc Ther 3:497-512. 2005..In particular, the authors review their effects on reductions in cardiovascular events and progression of chronic kidney disease, as well as the safety and tolerability of these agents...
Effect of intravenous iron on haemodialysis catheter microbial colonization and blood-borne infectionUrsula C Brewster
Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA
Nephrology (Carlton) 10:124-8. 2005..CONCLUSION: Intravenous iron is not associated with acute microbial growth in catheters or clinical infection. However, a trend towards increased catheter colonization following iron administration exists...
Drug-induced acute interstitial nephritisMark A Perazella
Section of Nephrology, Yale University School of Medicine, FMP 107, 330 Cedar Street, New Haven, CT 06520 8029, USA
Nat Rev Nephrol 6:461-70. 2010..In general, the prognosis for drug-induced AIN is good, and at least partial recovery of kidney function is normally observed. Early recognition is crucial because patients can ultimately develop chronic kidney disease...
Retroperitoneal bleed from acquired renal cystsJeffrey Stein
Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA
Semin Dial 19:256. 2006
Recent onset of focal arteriovenous graft swellingUrsula C Brewster
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA
Semin Dial 19:84. 2006
The role of aldosterone blockers in the management of chronic heart failureSteven G Coca
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA
Am J Med Sci 330:176-83. 2005..Herein, the pathophysiology of CHF, the beneficial role of aldosterone antagonists in this disease process, and potential adverse consequences of these agents are reviewed...
Calcific uremic arteriolopathy in a transplanted kidneyUrsula C Brewster
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA
Am J Med Sci 329:102-3. 2005..However, other organs may be involved. We report a case of a young man who developed renal failure in the transplanted kidney. Renal biopsy demonstrated myointimal calcification in the renal arteries consistent with this diagnosis...
Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfateDeepak Kadiyala
St Mary s Hospital, Waterbury, CT, USA
Am J Kidney Dis 53:133-7. 2009..Two patients received gadoversetamide and the third received gadodiamide. All 3 patients were treated early in their disease course with intravenous sodium thiosulfate and responded with improved skin changes and joint mobility...
Can dual blockade of the renin-angiotensin system reduce progression of kidney disease beyond monotherapy?Ursula C Brewster
Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, LMP 2071, 333 Cedar Street, New Haven, CT 06520 8029, USA
Expert Opin Drug Saf 3:9-23. 2004..The efficacy and safety of dual RAS blockade in proteinuric renal diseases will be examined. Finally, recommendations for utilising combined therapy with ACE inhibitors and ARBs will be provided...
Acute tubular necrosis and pre-renal acute kidney injury: utility of urine microscopy in their evaluation- a systematic reviewMehmet Kanbay
Section of Nephrology, Department of Medicine, Fatih University School of Medicine, Ankara, Turkey
Int Urol Nephrol 42:425-33. 2010..More often, tests such as fractional excretion of sodium (FeNa) and fractional excretion of urea (FeUrea) are used to differentiate these two causes of acute kidney injury...
Chronic kidney disease: a new approach to an old problemRobert F Reilly
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, USA
Conn Med 66:579-83. 2002..We herein review and summarize clinical practice guidelines put forward by the National Kidney Foundation Working Group to aid physicians in the diagnosis and management of CKD...
A case of extreme hemodynamic lability and hypocalcemiaFelix Knauf
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06520 8029, USA
Am J Med Sci 338:241-4. 2009..We discuss the initial management, diagnosis, and definitive therapy of this relatively rare type of pheochromocytoma...
Bisphosphonate nephrotoxicityMark A Perazella
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA
Kidney Int 74:1385-93. 2008..Available data suggest that ibandronate has a safe renal profile without evidence of nephrotoxicity, even in patients with abnormal baseline kidney function...
Calcific uremic arteriolopathy (calciphylaxis)Brian S Rifkin
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Conn, USA
Mayo Clin Proc 81:9. 2006
Access stenosis and stent fractureUrsula C Brewster
Department of Medicine, Yale University School of Medicine, New Haven, CT, USA
Am J Kidney Dis 47:A45, e35-6. 2006
Hip fractures in end-stage renal disease patients: incidence, risk factors, and preventionLisa Leinau
Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA
Semin Dial 19:75-9. 2006..Because falls occur frequently in the dialysis population, simple fall prevention may be one important way of protecting dialysis patients from the morbidity and mortality of hip fracture...
Percutaneous balloon cryoplasty: a new therapy for rapidly recurrent anastomotic venous stenoses of hemodialysis grafts?Brian S Rifkin
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
Am J Kidney Dis 45:e27-32. 2005..Cryotherapy with the cryoballoon (cryoplasty) may represent a useful therapy for patients with intractable stenoses at or near the venous anastomosis of arteriovenous grafts...
Acute interstitial nephritis associated with atazanavir, a new protease inhibitorUrsula C Brewster
Section of Nephrology, Yale University School of Medicine, New Haven, CT 06520-8029, USA
Am J Kidney Dis 44:e81-4. 2004..Renal biopsy showed acute interstitial nephritis. This is the first report of acute interstitial nephritis from atazanavir...
An unexpected finding on chest roentgenogram following hemodialysis catheter placementSwathi Singanamala
Department of Medicine, St Mary's Hospital, Waterbury, Connecticut, USA
Semin Dial 21:293-4. 2008
Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosisLes Lockridge
Department of Medicine, Section of Oncology and Section of Nephrology, Yale University, New Haven, CT 06529-8029, USA
Am J Kidney Dis 40:E2. 2002..We encountered a patient with Langerhans's histiocytosis who developed nephrotic syndrome and renal failure after pamidronate therapy. We describe the clinical and renal biopsy findings in this patient...
Pain and swelling at a Tenckhoff catheter tunnel siteSri Yarlagadda
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Semin Dial 19:438-9. 2006
Systemic diseases with renal manifestationsAsha Rajashekar
Division of Nephrology, Yale School of Medicine, 330 Cedar Street, FMP107, New Haven, CT 06510, USA
Prim Care 35:297-328, vi-vii. 2008..Dysproteinemias are associated with protean renal manifestations, and renal disease may be the presenting manifestation...
Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link?Mark A Perazella
Clin J Am Soc Nephrol 2:200-2. 2007
Kidney biopsy in HIV: beyond HIV-associated nephropathyDerek M Fine
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Am J Kidney Dis 51:504-14. 2008
Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic reviewDinna N Cruz
Department of Nephrology, San Bortolo Hospital, Vicenza, Italy
Am J Kidney Dis 48:361-71. 2006..We conducted a systematic review of published trials to determine whether periprocedural extracorporeal blood purification prevents RCIN...
Gadolinium use in patients with kidney disease: a cause for concernMark A Perazella
Semin Dial 20:179-85. 2007..Caution should be exercised when utilizing gadolinium as a contrast agent in patients with advanced CKD or ESRD...
Angiotensin-converting enzyme inhibitors and anemia in chronic kidney disease: a complex interactionAli K Abu-Alfa
Am J Kidney Dis 39:896-7. 2002
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?Mark A Perazella
Clin J Am Soc Nephrol 3:649-51. 2008
An odd case of hypertensionJohn E Aruny
Section of Interventional Radiology, Department of Diagnostic Imaging, Yale University School of Medicine, New Haven, Conn 06520-8029, USA
Am J Med 119:748-50. 2006
Intravenous iron and the risk of infection in end-stage renal disease patientsUrsula C Brewster
Section of Nephrology, Yale University School of Medicine, New Haven, 06520-8029, USA
Semin Dial 17:57-60. 2004..Practicing nephrologists should be aware of this issue, but should not hesitate to use IV iron in iron-deficient patients while avoiding the development of iron overload and administration of iron to patients who have active infection...
Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitorAshutosh Singh
Department of Pathology, University of Tennessee Health Sciences Center, Memphis, TN, USA
Am J Kidney Dis 49:153-7. 2007..A steady improvement in renal function subsequently was observed. Results of a repeated 24-hour urine oxalate collection performed 3 weeks later when kidney function had improved were within normal limits...
Acute tubulointerstitial nephritis associated with celecoxibUrsula C Brewster
Nephrol Dial Transplant 19:1017-8. 2004
Prevention of contrast-induced nephropathy in high-risk patients with hemofiltrationSteven G Coca
Am J Med 120:e9; author reply e11. 2007
Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failureBrian S Rifkin
Am J Med 117:282-4. 2004
North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE CriteriaDinna N Cruz
Department of Nephrology and Intensive Care, San Bortolo Hospital, Vicenza, Italy
Clin J Am Soc Nephrol 2:418-25. 2007..3% of ICU patients requiring renal replacement therapy. Sepsis was a significant contributing factor. Overall mortality was between 30 and 42%, and was highest among those in RIFLE class F...
Drug-induced renal failure: a focus on tubulointerstitial diseaseGlen S Markowitz
Department of Pathology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA
Clin Chim Acta 351:31-47. 2005..This review focuses on the multitude of patterns of drug-induced renal failure due to tubulointerstitial disease...
